To include your compound in the COVID-19 Resource Center, submit it here.

CBMG raises about $31M for gene therapy in China

Sailing Capital Overseas Investment Ltd. and its affiliates invested $30.5 million in cell therapy company Cellular Biomedicine Group Inc. (NASDAQ:CBMG) through the sale of 1.7 million shares at $17.80 in a private

Read the full 329 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE